TEANECK, N.J., June 3, 2015 /PRNewswire/ -- Cognizant (NASDAQ: CTSH) today announced that Lumenis Ltd. (NASDAQ: LMNS), the world's largest energy-based medical device company for aesthetic, surgical and ophthalmology applications, has deployed Cognizant MedVantage™, a cloud-based integrated complaint handling solution.

Lumenis' ground-breaking products using laser, intense pulsed light (IPL) and radio frequency (RF) technologies have redefined medical treatments and set numerous technological and clinical benchmarks and standards. By utilizing Cognizant's MedVantage™ Complaint Management Solution, device and other issues are automatically and precisely tracked, classified and maintained online from start to finish for improved service, efficiency and reporting.

"Lumenis has an uncompromising commitment to improving the health and well-being of our patients. The Cognizant MedVantage solution integrates seamlessly with our existing Salesforce.com infrastructure and provides all of our stakeholders with a critical end-to-end complaint management solution," said Amir Belferman, Global CIO, Lumenis. "MedVantage enables us to not only manage product complaints but also related adverse events, Medical Device Reporting (MDR)/Vigilance reporting, corrective and preventive action (CAPA) activities, and internal/external audit tracking. Our regional offices recently went 'live' with this new solution, enhancing our ability to analyze global post market data from anywhere in the world." 

"This global access to data will help our engineering and R&D departments make more rapid product improvement decisions, ultimately affecting our customers' satisfaction and their patients' outcomes," said Yossi Sabach, Project Manager of Global IT Complaint Management, Lumenis. "With this solution, we have expanded global outreach and will continue to do so going forward."

"With Lumenis deploying more of its innovative medical devices worldwide, it is leveraging the scale of the cloud to implement a highly collaborative digital solution that can be quickly adopted in multiple markets," said Shankar Narayanan, Vice President and Global Markets Leader of the Life Sciences practice at Cognizant. "Maintaining a standard of rapid response and agility in today's quickly changing regulatory environment is critical to meeting and exceeding customer expectations. MedVantage, one of the digital solutions within our Life Sciences practice, is specifically designed as a turnkey solution to provide distinct scale, cost and business advantages compared to complex traditional systems."

About Cognizant's Healthcare and Life Sciences Practice
Cognizant's Healthcare and Life Sciences practice is committed to helping change millions of lives for the better by partnering with clients to build solutions to healthcare challenges, continually improve the way they do business, set the pace in clinical development, strengthen their regulatory infrastructure, and increase competitiveness. With approximately $3.5 billion in annualized revenue, Cognizant's healthcare practice is consistently ranked among the top 10 on the Healthcare Informatics Top 100, Cognizant serves 28 of the top 30 global pharmaceutical companies, 16 of the top 20 health plans in the U.S., 4 of the top 5 pharmacy benefit management companies in the U.S., 9 of the top 10 biotech companies, and 12 of the top 15 medical device companies. With a large team of dedicated professionals including doctors, pharmacologists, physicians, biomedical engineers, pharmacists, biostatisticians, medical writers, and GxP consultants, the practice provides domain-aligned consulting, IT, business process and analytics solutions globally.

About Lumenis
Lumenis (NASDAQ: LMNS) is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology, and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For nearly 50 years, Lumenis' ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods in each and every one of the verticals we operate in. For more information visit:  www.lumenis.com

About Cognizant
Cognizant (NASDAQ: CTSH) is a leading provider of information technology, consulting, and business process outsourcing services, dedicated to helping the world's leading companies build stronger businesses. Headquartered in Teaneck, New Jersey (U.S.), Cognizant combines a passion for client satisfaction, technology innovation, deep industry and business process expertise, and a global, collaborative workforce that embodies the future of work. With over 100 development and delivery centers worldwide and approximately 217,700 employees as of March 31, 2015, Cognizant is a member of the NASDAQ-100, the S&P 500, the Forbes Global 2000, and the Fortune 500 and is ranked among the top performing and fastest growing companies in the world. Visit us online at www.cognizant.com or follow us on Twitter: Cognizant.

Logo - http://photos.prnewswire.com/prnh/20110329/NY67603LOGO

SOURCE Cognizant